Rational Design, Synthesis, and Molecular Docking of Novel Terpene Analogues of Imatinib, and Their Inhibition on Downstream BCR-ABL Signaling. [PDF]
Mihaylova R +6 more
europepmc +1 more source
An overview of strategies and challenges adopted to silence BCR-ABL gene by small interfering RNA. [PDF]
Fancello L, Manconi M, Manca ML.
europepmc +1 more source
RETRACTED: Li et al. Blockade of Y177 and Nuclear Translocation of Bcr-Abl Inhibits Proliferation and Promotes Apoptosis in Chronic Myeloid Leukemia Cells. <i>Int. J. Mol. Sci.</i> 2017, <i>18</i>, 537. [PDF]
Li Q +6 more
europepmc +1 more source
Natural Products Targeting BCR-ABL: A Plant-Based Approach to Chronic Myeloid Leukemia Treatment. [PDF]
Pechlivani L +4 more
europepmc +1 more source
Second- and Third-Generation BCR-ABL Tyrosine Kinase Inhibitors and the Risk of Pulmonary Arterial Hypertension: A Prevalent New-User Design. [PDF]
Jambon-Barbara C +8 more
europepmc +1 more source
Combined targeting of GPX4 and BCR-ABL tyrosine kinase selectively compromises BCR-ABL+ leukemia stem cells. [PDF]
Zeng C +14 more
europepmc +1 more source
Olverembatinib, a novel BCR-ABL tyrosine kinase inhibitor, exhibits anti-tumor activity and synergizes with gemcitabine in pancreatic ductal adenocarcinoma. [PDF]
Xia Z +11 more
europepmc +1 more source

